Abstract:Background: Diabetes mellitus is the third-largest non-communicable chronic disease worldwide. There are many effective drugs, but the long-term use of these clinical drugs may cause various side effects. Therefore, it is urgent to develop new antidiabetic molecules with higher efficacy and lower toxicity. Methods: Fifteen new 3-aryl-1-(5-methylisoxazol-3-ylamino)-1-(4-nitrophenyl)propan-1-one were synthesized directly through the Mannich reaction of 4-nitroacetophenone, 3-amino-5- methylisoxazole and aromatic aldehydes catalyzed by concentrated hydrochloric acid. The molecular structures of the products were fully characterized by 1H NMR, 13C NMR, ESI MS and HRMS. The peroxisome proliferator-activated receptor (PPAR) response element and α-glucosidase inhibitory activity of these compounds were evaluated in vitro. Molecular docking, molecular physical parameters calculation, and molecular toxicity prediction were performed to analyze the structure- activity relationship and evaluate the druggability of these compounds theoretically. Results: All compounds exhibited weak antidiabetic activities, but compound 15 showed promising as a high performance, dual-target antidiabetic lead compound with peroxisome proliferatoractivated receptor (PPAR) response element relative agonist activity of 99.55% at 27.2 nmol·mL−1 and α-glucosidase inhibitory activity of 35.21% at 13.6 nmol·mL−1. All compounds obtained may have no cardiotoxicity, no acute toxicity, no carcinogenic, and within safe range of mutagenic risk. Conclusion: This study identified a potential PPAR lead molecule and presented an unusual strategy for antidiabetic drug development.

Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents.

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Design, Synthesis and Evaluation of Phenylfuroxan Nitric Oxide-Donor Phenols As Potential Anti-Diabetic Agents

Synthesis and Biological Evaluation of Novel Neoflavonoid Derivatives As Potential Antidiabetic Agents

Synthesis, Nitric Oxide Release, and Dipeptidyl Peptidase-4 Inhibition of Sitagliptin Derivatives As New Multifunctional Antidiabetic Agents

Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.

Synthesis, Characterization and Vasculoprotective Effects of Nitric Oxide-Donating Derivatives of Chrysin.

Design, Synthesis and Biological Evaluation of GY3-based Derivatives for Anti-Type 2 Diabetes Activity.

Synthesis and Investigation on the Antidiabetic Effect of 3-Aryl-1-(5-methylisox Azol-3-ylamino)-1-(4-nitrophenyl) Propan-1-one

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Synthesis of novel imidazolidine-2,4-dione derivatives as potential antidiabetic agents

Synthesis of Diosgenin-Ibuprofen Derivatives and Their Activities Against Insulin-Dependent Diabetes Mellitus

Synthesis and in Vivo Acute Antihyperglycemic Evaluation of Novel Isosteviol Derivatives

Synthesis and Preliminary Biologic Activity Evaluation of Nitric Oxide-Releasing Andrographolide Derivatives in RIN-m Cells

Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives.

Design, Synthesis and Biological Evaluation of Nitric Oxide Releasing Derivatives of Dapagliflozin As Potential Anti-Diabetic and Anti-Thrombotic Agents.

Synthesis,Characterization and Antidiabetic Activities of Novel Genipin Derivatives

Synthesis & Alpha-Glucosidase Inhibitory & Glucose Consumption-Promoting Activities O Flavonoid-Coumarin Hybrids

Design, Synthesis and Bioactivity Studies of Novel Sugar Derivatives

Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents

Synthesis and activity of arylcoumarin derivatives with therapeutic effects on diabetic nephropathy